Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study

OBJECTIVE: To investigate whether extending adjuvant temozolomide (TMZ) improved the prognosis of newly diagnosed glioblastoma (GBM) patients with different mutation statuses of O(6)-methylguanine DNA methyltransferase (MGMT), isocitrate dehydrogenase 1 (IDH1), p53 and different expression level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Wang, Tingting, Liu, Wanming, Qiu, Hui, Zhang, Nie, Chen, Xueting, Ding, Xin, Zhang, Longzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723160/
https://www.ncbi.nlm.nih.gov/pubmed/36483042
http://dx.doi.org/10.3389/fonc.2022.1000501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723160/
https://www.ncbi.nlm.nih.gov/pubmed/36483042
http://dx.doi.org/10.3389/fonc.2022.1000501

Ejemplares similares